These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22705497)

  • 1. Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.
    Pasquini MC; Voltarelli J; Atkins HL; Hamerschlak N; Zhong X; Ahn KW; Sullivan KM; Carrum G; Andrey J; Bredeson CN; Cairo M; Gale RP; Hahn T; Storek J; Horowitz MM; McSweeney PA; Griffith LM; Muraro PA; Pavletic SZ; Nash RA
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1471-8. PubMed ID: 22705497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.
    Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R
    Haematologica; 2010 Feb; 95(2):284-92. PubMed ID: 19773265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hematopoietic stem cell transplantation for autoimmune disease--is it now ready for prime time?
    Atkins HL; Muraro PA; van Laar JM; Pavletic SZ
    Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S177-83. PubMed ID: 22226104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.
    Passweg JR; Baldomero H; Ansari M; Baerlocher GM; Bargetzi M; Chalandon Y; Duchosal MA; Gerull S; Güngör T; Halter JP; Heim D; Hess U; Leibundgut K; Masouridi-Levrat S; Müller A; Nair G; Pabst T; Renner C; Schmidt A; Stussi G; Nicoloso de Faveri G; Schanz U; For The Swiss Blood Stem Cell Transplantation Group Sbst
    Swiss Med Wkly; 2018; 148():w14589. PubMed ID: 29493715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
    Thakar MS; Broglie L; Logan B; Artz A; Bunin N; Burroughs LM; Fretham C; Jacobsohn DA; Loren AW; Kurtzberg J; Martinez CA; Mineishi S; Nelson AS; Woolfrey A; Pasquini MC; Sorror ML
    Blood; 2019 Feb; 133(7):754-762. PubMed ID: 30545834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
    Maramattom LV; Hari PN; Burns LJ; Carreras J; Arcese W; Cairo MS; Costa LJ; Fenske TS; Lill M; Freytes CO; Gale RP; Gross TG; Hale GA; Hamadani M; Holmberg LA; Hsu JW; Inwards DJ; Lazarus HM; Marks DI; Maloney DG; Maziarz RT; Montoto S; Rizzieri DA; Wirk B; Gajewski JL
    Biol Blood Marrow Transplant; 2013 Feb; 19(2):173-9. PubMed ID: 23200705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
    Cowan AJ; Baldomero H; Atsuta Y; Mikhael J; Aljurf M; Seber A; Greinix H; Koh M; Worel N; Libby EN; Pasquini M; Galeano S; Saber W; Iida M; Jaimovich G; Rolon JM; Kodera Y; Benakli M; Nosa BG; Elhaddad A; Szer J; Passweg J; Kroeger N; Weisdorf D; Niederwieser D
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2372-2377. PubMed ID: 32846200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
    Lazarus HM; Zhang MJ; Carreras J; Hayes-Lattin BM; Ataergin AS; Bitran JD; Bolwell BJ; Freytes CO; Gale RP; Goldstein SC; Hale GA; Inwards DJ; Klumpp TR; Marks DI; Maziarz RT; McCarthy PL; Pavlovsky S; Rizzo JD; Shea TC; Schouten HC; Slavin S; Winter JN; van Besien K; Vose JM; Hari PN
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):35-45. PubMed ID: 20053330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.
    McCarthy PL; Hahn T; Hassebroek A; Bredeson C; Gajewski J; Hale G; Isola L; Lazarus HM; Lee SJ; Lemaistre CF; Loberiza F; Maziarz RT; Rizzo JD; Joffe S; Parsons S; Majhail NS
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1116-23. PubMed ID: 23660172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
    Buchbinder D; Brazauskas R; Bo-Subait K; Ballen K; Parsons S; John T; Hahn T; Sharma A; Steinberg A; D'Souza A; Kumar AJ; Yoshimi A; Wirk B; Shaw B; Freytes C; LeMaistre C; Bredeson C; Dandoy C; Almaguer D; Marks DI; Szwajcer D; Hale G; Schouten H; Hashem H; Schoemans H; Murthy HS; Lazarus HM; Cerny J; Tay J; Yared JA; Adekola K; Schultz KR; Lehmann L; Burns L; Aljurf M; Diaz MA; Majhail N; Farhadfar N; Kamble R; Olsson R; Schears R; Seo S; Beattie S; Chhabra S; Savani BN; Badawy S; Ganguly S; Ciurea S; Marino S; Gergis U; Kuwatsuka Y; Inamoto Y; Khera N; Hashmi S; Wood W; Saber W
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):553-561. PubMed ID: 31726205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic cell transplantation for benign hematological disorders and solid tumors.
    Storb RF; Lucarelli G; McSweeney PA; Childs RW
    Hematology Am Soc Hematol Educ Program; 2003; ():372-97. PubMed ID: 14633791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
    Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
    Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
    Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
    Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.
    Giralt S; Costa LJ; Maloney D; Krishnan A; Fei M; Antin JH; Brunstein C; Geller N; Goodman S; Hari P; Logan B; Lowsky R; Qazilbash MH; Sahebi F; Somlo G; Rowley S; Vogl DT; Vesole DH; Pasquini M; Stadtmauer E
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):798-804. PubMed ID: 31756536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.
    Sullivan KM; Muraro P; Tyndall A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S48-56. PubMed ID: 19895895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.